Introduction
Because Fahr had previously described a case report of a man with hypoparathyroidism and calcification of the basal ganglia (BG), all forms of bilateral calcifications of the BG and other parts of the brain are now associated with Fahr's name. 1, 2 Because these calcifications tend to show a predilection for the dentate nuclei and BG, the descriptive term ''bilateral striopallidodentate calcinosis (BSPDC)'' has been suggested, 3, 4 in addition to being referred to as Fahr's disease. 5 Common lesions of BSPDC of the BG generally occur in the globus pallidus, dentate nucleus (DN) of cerebellum, thalamus and centrum semiovale. 1 Because calcium and other mineral deposits are the major components accounting for its radiological appearance, a computed tomography (CT) scan is considered to be more sensitive than a magnetic resonance imaging (MRI) scan to search for deposits of BSPDC. 4 The most common manifestations of BSPDC are movement disorders such as parkinsonism and other hyperkinetic movements, which are followed by cognitive impairment, cerebellar ataxia and speech disorder. Paroxysmal kinesigenic dyskinesia (PKD) consists of any combination of dystonic postures, chorea, athetosis and ballism. PKD is brief, usually lasting seconds up to 5 min, and is precipitated by a sudden movement or by startles. 6 Although the etiology of most PKD case reports has been idiopathic, symptomatic or secondary PKD has also been established. 6 Specifically, PKD has been reported to occur with BSPDC without hypoparathyroidism. 7 However, the pathophysiology of PKD is still unclear and its relationship with epilepsy has remained unresolved. Here, we report the case of a 35-year-old-man with PKD for 19 years. He has also been treated with carbamazepine, and his symptoms have improved.
An assessment using brain imaging (CT) of this case and a review of the related literature was performed to more clearly define the effects of BSPDC in the pathogenesis of PKD.
Case report
A 35-year-old man presented with intermittent paroxysmal episodic involuntary movements since the age of 16 years. He reported a stiffening of his legs, inversion and dystonia of his feet, flexion of his right hands into a clawed position, and tightness in his neck which are consistent with PKD. Dystonia was revealed on both feet; in particular, it was more frequent and severe on the right foot. The duration of the episode was 5-10 s. During an episode, he was unable to stand, was poorly mobile, and would sometimes fall down. However, no pain or loss of consciousness occurred during the attacks. Large meals or prolonged rest did not trigger the events, although most of the episodes occurred after standing up suddenly from a seated position after a prolonged rest state. The episodes were occurred approximately 20-30 times per day. The patient denied experiencing any auras, rhythmic twitching, tongue-biting, loss of bowel or bladder control, postictal sleepiness, or headaches.
His birth, delivery, and development were unremarkable. He had no other significant medical history, and there was a lack of a family history of neurological or psychiatric disorders. A general physical and neurological examination produced normal results. An electroencephalogram recording did not reveal any abnormality. A CT scan revealed a bilateral calcification in the BG and DN of the cerebellum (Fig. 1) . Laboratory studies revealed normal levels of calcium serum (9.1 mg/dL), inorganic phosphorus (3.5 mg/dL), and parathyroid hormone (30.38 pg/ml). Serum free T4 was slightly elevated (1.81 ng/dL); however, serum T3, T4, TSH, free T4, thyroglobulin Ab, and microsomal Ab were within the normal limits in a follow-up thyroid function exam. Moreover, the serum ceruloplasmin and copper levels were normal. An antinuclear antibody was negative. Other routine hematological examinations (hemoglobin, total and differential count) and blood biochemistry (glucose, creatine, liver function test, sodium, potassium) were within the normal limits. Genetic test of PRRT2 mutation on the chromosome 16, which has been related with infantile seizure and adolescent movement disorder PKD. 8 Despite of this very helpful suggestion, because he did not want to do any more laboratory tests, we could not perform the gene study. Furthermore, his involuntary movements had improved in response to carbamazepine (100 mg/day).
Discussion
The diagnostic criteria of PKD include an identified kinesigenic trigger for the attacks, a short attack duration (<5 min), no pain or loss of consciousness during the attacks, a usual age of onset between 1 and 20 years (if there is no family history of PKD), the exclusion of other organic diseases, normal results of an interictal neurological examination, and control of the attacks with a lowdose of carbamazepine or phenytoin. 9, 10 The hyperkinetic movements exhibited by our patient satisfied these criteria; however, we suspected his attacks to be a BSPDC of symptomatic cases in PKD because of the calcification of the BG and DN of the cerebellum in a CT scan. BSPDC is the rare cause of secondary cases in PKD. Although neuronal degeneration and gliosis surrounding the calcium accumulation of the BG are major pathologies, 5 the exact reason why the BG is vulnerable to calcium deposits has not yet been fully established. The major differential diagnosis of BSPDC is hypoparathyroidism. Our patient's serum laboratory results indicated that his calcium and parathyroid hormone levels were all normal. Over the years, a substantial debate has occurred whether PKD is an epileptic or a non-epileptic disorder. 11 The epileptic origin is clinically supported by the brief, paroxymal, stereotyped nature of the attacks and the dramatic response to anticonvulsants. 9 PKC has been suggested to a peculiar form of reflex epilepsy. 12 In addition, PKC was co-occurred in families affected by the infantile convulsions and choreoathetosis (ICCA) syndrome, and they were associated with PRRT2 mutations in the same gene on the chromosome16. 8 However, no typical ictal or interictal changes in the EEG, the lack of a family or past medical history of epilepsy, and the preservation of consciousness support the idea that PKD is not an epileptic disorder. 13 Thus, some studies suggest a subcortical origin of the epileptogenic source in the BG.
11,13
Other studies have considered PKD to be a BG disorder rather than a form of epilepsy. 14, 15 Recently, a neurophysiological study based on the dysfunction of the BG circuit suggests that an impaired cortical and spinal inhibition is important for the differentiation of PKD from epilepsy. 16 In addition, a cerebral perfusion SPECT abnormality of the bilateral caudate nuclei in PKD supports the BG theory. 15 However, the pathogenic association between PKD and BSPDC has not been fully established. Based on our current knowledge, damage to the BG or to the cerebellar loop of the motor areas of the cortex leads to motor symptoms. 17 Because of no family history of movement disorders and past medical history of infantile seizure, he is able to be clinically and radiologically diagnosed with idiopathic primary BSPDC despite of unperforming genetic study of PRRT2 mutation. Therefore, we suggest that a broad and massive bilateral calcification of the BG and cerebellum may drive PKD in our patient.
To our knowledge, this is the second case of BSPDC who presented with PKD, which strongly supports the BG theory.
